Dodge & Cox

Holding/activity history for  Novartis AG (NVS)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 9,440,008 0.97 $115.02
2024   Q2 9,440,008 0.95 $106.46
2024   Q1 9,440,008 0.84 $96.73
2023   Q4 9,440,008 0.98 Reduce 20.00% 0.25 $100.97
2023   Q3 11,800,308 1.32 Reduce 0.18% 0.00 $101.86
2023   Q2 11,821,508 1.31 Reduce 20.71% 0.34 $100.91
2023   Q1 14,909,200 1.56 $92.00
2022   Q4 14,909,200 1.55 Buy 1.55 $90.72
2022   Q3 0 0 Sell 100.00% 1.58
2022   Q2 15,696,200 1.58 Reduce 18.91% 0.37 $84.53
2022   Q1 19,357,100 1.76 $87.75
2021   Q4 19,357,100 1.77 Reduce 3.28% 0.06 $87.47
2021   Q3 20,013,900 1.81 Add 25.40% 0.37 $81.78
2021   Q2 15,959,756 1.66 Add 12.72% 0.19 $91.24
2021   Q1 14,158,400 1.54 Add 2.08% 0.03 $85.48
2020   Q4 13,870,000 1.87 Reduce 0.16% 0.00 $94.43
2020   Q3 13,892,700 2.01 Add 13.94% 0.25 $86.96
2020   Q2 12,192,700 1.79 Reduce 14.84% 0.31 $87.34
2020   Q1 14,316,800 2.32 Reduce 13.97% 0.38 $82.45
2019   Q4 16,641,600 2.14 Reduce 4.17% 0.09 $94.69
2019   Q3 17,366,300 2.23 $86.90
2019   Q2 17,366,300 2.30 Reduce 9.61% 0.24 $91.31
2019   Q1 19,212,800 2.73 Reduce 0.20% 0.01 $96.14
2018   Q4 19,251,900 2.73 Reduce 12.81% 0.40 $85.81
2018   Q3 22,080,200 2.60 Add 1.61% 0.04 $86.16
2018   Q2 21,730,200 2.38 $75.54
2018   Q1 21,730,200 2.57 $80.85
2017   Q4 21,730,200 2.61 Reduce 0.53% 0.01 $83.96
2017   Q3 21,845,500 2.78 Reduce 7.72% 0.23 $85.85
2017   Q2 23,673,500 3.07 $83.47
2017   Q1 23,673,500 2.77 Add 16.09% 0.38 $74.27
2016   Q4 20,392,957 2.48 Add 8.63% 0.20 $72.84
2016   Q3 18,773,500 2.66 Reduce 1.98% 0.05 $78.96
2016   Q2 19,153,500 2.97 Add 0.66% 0.02 $82.51
2016   Q1 19,028,500 2.58 Add 1.06% 0.03 $72.44
2015   Q4 18,828,500 3.02 Reduce 0.28% 0.01 $86.04
2015   Q3 18,880,700 3.28 Reduce 3.57% 0.12 $91.92
2015   Q2 19,580,700 3.24 Reduce 7.25% 0.25 $98.34
2015   Q1 21,110,700 3.52 $98.61
2014   Q4 21,110,700 3.28 Reduce 2.76% 0.09 $92.66
2014   Q3 21,710,700 3.53 Reduce 1.03% 0.04 $94.13
2014   Q2 21,936,900 3.43 Add 18.66% 0.54 $90.53
2014   Q1 18,486,900 2.89 Reduce 1.41% 0.04 $85.02
2013   Q4 18,750,400 2.79 Reduce 0.53% 0.01 $80.38
2013   Q3 18,850,400 2.97 $76.71
2013   Q2 18,850,400 2.92 Reduce 0.66% 0.02 $70.71
2013   Q1 18,974,700 3.06 $71.24
2012   Q4 18,974,700 3.04 Add 6.22% 0.18 $63.30
2012   Q3 17,863,300 2.74 Add 9.17% 0.23 $61.26
2012   Q2 16,363,300 2.43 Reduce 0.61% 0.01 $55.90
2012   Q1 16,463,300 2.26 Reduce 3.81% 0.09 $55.41
2011   Q4 17,114,600 2.69 Reduce 6.55% 0.19 $57.17
2011   Q3 18,314,600 3.01 Reduce 15.70% 0.56 $55.77
2011   Q2 21,726,300 3.06 $61.11
2011   Q1 21,726,300 2.65 Reduce 0.52% 0.01 $54.35
2010   Q4 21,840,400 3.02 Reduce 2.70% 0.08 $58.95
2010   Q3 22,446,300 3.28 Reduce 11.86% 0.44 $57.67
2010   Q2 25,465,500 3.38 $48.32
2010   Q1 25,465,500 3.28 $54.10
2009   Q4 25,465,500 3.53 Reduce 2.30% 0.08 $54.43
2009   Q3 26,065,500 3.38 $50.38
2009   Q2 26,065,500 3.23 Reduce 0.05% 0.00 $40.79
2009   Q1 26,078,700 3.74 Reduce 6.12% 0.24 $37.83
2008   Q4 27,778,700 4.32 Reduce 2.46% 0.11 $49.76
2008   Q3 28,478,700 3.41 Reduce 3.74% 0.13 $52.84
2008   Q2 29,584,700 3.15 Add 0.04% 0.00 $55.04
2008   Q1 29,573,700 2.84 $51.23
2007   Q4 29,573,700 2.57 Add 11.30% 0.26 $54.31
2007   Q3 26,572,200 2.15 Add 38.37% 0.59 $54.96
2007   Q2 19,204,200 1.53 Buy 1.53 $56.07